Zobrazeno 1 - 10
of 316
pro vyhledávání: '"John M Vierling"'
Autor:
Wayne Eskridge, John M Vierling, Wayne Gosbee, Gabriella A Wan, May-Linh Hyunh, Henry E Chang
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260320 (2021)
The screening for undiagnosed non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (SUNN) study was a population-based screening study that aimed to provide proof of concept to encourage community-level screening and detection for this
Externí odkaz:
https://doaj.org/article/6db50ebd9eee47edb077a78a6d7f5ec2
Autor:
Ayse L Mindikoglu, Cristian Coarfa, Antone R Opekun, Vijay H Shah, Juan P Arab, Konstantinos N Lazaridis, Nagireddy Putluri, Chandrashekar R Ambati, Matthew J Robertson, Sridevi Devaraj, Prasun K Jalal, Abbas Rana, John A Goss, Thomas C Dowling, Matthew R Weir, Stephen L Seliger, Jean-Pierre Raufman, David W Bernard, John M Vierling
Publikováno v:
Future Science OA, Vol 6, Iss 2 (2020)
Aim: To assess the ability of signature metabolites alone, or in combination with the model for end-stage liver disease-Na (MELD-Na) score to predict mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cho
Externí odkaz:
https://doaj.org/article/67b9ede47d7a43a09cc32b36b4d67d97
Autor:
Jessica I. Sanchez, Antoine C. Fontillas, Suet-Ying Kwan, Caren I. Sanchez, Tiffany L. Calderone, Jana L. Lee, Ahmed Elsaiey, Darrel W. Cleere, Peng Wei, John M. Vierling, David W. Victor, Laura Beretta
Publikováno v:
JHEP Reports, Vol 6, Iss 8, Pp 101119- (2024)
Background & Aims: The effectiveness of surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is limited, due to inadequate risk stratification and suboptimal performance of current screening modalities. Methods: We developed a m
Externí odkaz:
https://doaj.org/article/abe801a0a33d45afa78bfe1046253a94
Publikováno v:
Frontiers in Gastroenterology, Vol 3 (2024)
BackgroundWilson disease (WD) is a rare and potentially fatal genetic disorder caused by accumulation of toxic levels of copper. Current treatments include chelating agents and/or zinc. We characterized real-world US treatment patterns in patients wi
Externí odkaz:
https://doaj.org/article/9e13711345fe47a3be21442b88e9d97a
Publikováno v:
Frontiers in Gastroenterology, Vol 2 (2024)
IntroductionThere are limited data from the United States regarding the real-world signs and symptoms of Wilson disease (WD). This retrospective, observational medical chart review was conducted to identify real-world characteristics of patients with
Externí odkaz:
https://doaj.org/article/1fdf5400e80f4bf7819aa3c0c2c2cdc8
Autor:
Arun J. Sanyal, Patricia Lopez, Eric J. Lawitz, Kathryn J. Lucas, Juergen Loeffler, Won Kim, George B. B. Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H. Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M. Sheikh, John M. Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R. I. Carbarns, Sophie Lamle, Miljen Martic, Nikolai V. Naoumov, Clifford A. Brass
Publikováno v:
Nature Medicine. 29:392-400
The multimodal activities of farnesoid X receptor (FXR) agonists make this class an attractive option to treat nonalcoholic steatohepatitis. The safety and efficacy of tropifexor, an FXR agonist, in a randomized, multicenter, double-blind, three-part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dc2773f3efdbc3a1d53a40666606e76
https://doi.org/10.1038/s41591-022-02200-8
https://doi.org/10.1038/s41591-022-02200-8
Autor:
Teddy Sutardji Nagaria, Isaac Raijman, Mohamed O. Othman, Gary Lloyd Horn, John M. Vierling, Juhi Mahadik, Sadhna Dhingra
Publikováno v:
iGIE. 1:62-76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::088988e1e9690c181c3484d5b9b7bdb1
https://doi.org/10.1016/j.igie.2022.10.010
https://doi.org/10.1016/j.igie.2022.10.010
Autor:
Christopher L. Bowlus, Michael R. Galambos, Richard J. Aspinall, Gideon M. Hirschfield, David E.J. Jones, Yvonne Dörffel, Stuart C. Gordon, Stephen A. Harrison, Andreas E. Kremer, Marlyn J. Mayo, Paul J. Thuluvath, Cynthia Levy, Mark G. Swain, Guy W. Neff, David A. Sheridan, Carmen M. Stanca, Christoph P. Berg, Aparna Goel, Mitchell L. Shiffman, John M. Vierling, Pol Boudes, Alexandra Steinberg, Yun-Jung Choi, Charles A. McWherter
Publikováno v:
Journal of Hepatology. 77:353-364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30eb0284f4c72c499f63b694e0199fe6
https://doi.org/10.1016/j.jhep.2022.02.033
https://doi.org/10.1016/j.jhep.2022.02.033
Autor:
Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander Gerbes, Arie Regev, Benedetta Terziroli Beretta-Piccoli, Christoph Schramm, David E. Kleiner, Eleonora De Martin, Gerd A. Kullak-Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, Maria Carlota Londoño, Mark Avigan, Mercedes Robles-Diaz, Miren García-Cortes, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak J. Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M Isabel Lucena, Giorgina Mieli-Vergani, Diego Vergani, Einar S. Björnsson, Fernando Bessone, Raymundo Paraná, Gideon M. Hirschfield, Jack Uetrecht, Alessio Gerussi, Ana Lleo, Annarosa Floreani, Federica Invernizzi, Federica Pedica, Marco Carbone, Massimo Colombo, Jose Pinazo, Aida Ortega-Alonso, Judith Sanabria-Cabrera, Camilla Stephens, Ismael Alvarez-Alvarez, Hao Niu, Marina Villanueva, Daniel di Zeo, Antonio Segovia, Gonzalo Matilla, Alejandro Cueto, Enrique del Campo, Agustin Castiella, Mar Riveiro-Barciela, Maria Buti, Dermot Gleeson, Jessica Dyson, Rosa Miquel, Amber Bozward, Nelia Hernandez, Averell H. Sherker, Jay H. Hoofnagle, Katrina Loh, Ayako Suzuki, Mariana Cardoso, Yimin Mao, Elena Gómez Dominguez
Publikováno v:
Andrade, Raúl J; Aithal, Guruprasad P; de Boer, Ynto S; Liberal, Rodrigo; Gerbes, Alexander; Regev, Arie; Beretta-Piccoli, Benedetta Terziroli; Schramm, Christoph; Kleiner, David E; De Martin, Eleonora; Kullak-Ublick, Gerd A; Stirnimann, Guido; Devarbhavi, Harshad; Vierling, John M; Manns, Michael P; Sebode, Marcial; Londoño, Maria Carlota; Avigan, Mark; Robles-Diaz, Mercedes; García-Cortes, Miren; ... (2023). Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. (In Press). Journal of hepatology Elsevier 10.1016/j.jhep.2023.04.033
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarizes the major topics discussed at a joint International Conference held be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dffa390abd8e877c42756939cdbc7d2a
https://boris.unibe.ch/182454/1/1-s2.0-S0168827823003203-main.pdf
https://boris.unibe.ch/182454/1/1-s2.0-S0168827823003203-main.pdf
Autor:
Orlee R. Guttman, Bettina E. Hansen, Sonya A. MacParland, Cynthia Levy, John M. Vierling, Pere Santamaria, Gideon M. Hirschfield, Maryam Ebadi, Fernanda de Quadros Onófrio, Angela Cheung, Jessica R. Allegretti, Nanda Kerkar, Wayne Bai, Catherine Vincent, Susan Gilmour, Amanda Ricciuto, Ashley Stueck, Fernando Alvarez, Mark G. Swain, Aldo J. Montano-Loza, Sumera Rizvi, Andrew Mason, Aliya Gulamhusein, David Jones
Publikováno v:
Canadian Liver Journal. 4:401-425
Autoimmune liver disease (AILD) spans a spectrum of chronic disorders affecting the liver parenchyma and biliary system. Three main categories of AILD are autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e8c4cd9ad6ba36a867cdaf5c49e87b
https://doi.org/10.3138/canlivj-2021-0006
https://doi.org/10.3138/canlivj-2021-0006